Endometrial atypical hyperplasia, also known as endometrial atypical hyperplasia, is regulated in relation to the patient’s age. Younger patients with fertility requirements can be treated with progesterone, while older patients without fertility requirements can be treated with hysterectomy.
Endometrial atypical hyperplasia is a kind of pathologic biopsy result of endometrium, which indicates the possibility of precancerous lesions. For patients who are within forty years of age and have the requirement of having children, they can be given highly effective progesterone treatment, such as medroxyprogesterone acetate and medroxyprogesterone treatment. Every 3-6 months, the endometrial lesions will be reviewed through hysteroscopy to see if they have been reversed, and regular review is also necessary to avoid recurrence.
Patients with atypical endometrial hyperplasia who are over 40 years old and have no requirement for childbearing, hysterectomy can effectively prevent endometrial cancer, and women who are not menopausal can keep their ovaries.
Women who have been examined for atypical endometrial hyperplasia should go to the hospital to receive regular treatment, rather than privately regulating themselves.